Cancer / Immunology
Prenetics Forms Advisory Board for Precision Oncology Strategy
Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Adviso...
March 02, 2023 | News
JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma
Primary hepatic cancer is a common malignant tumor of the digestive system worldwide, with high malignancy and hepatic prognosis. As the most common pathol...
March 01, 2023 | News
AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study
To date, the study has enrolled over 18,000 individuals from a general population of 230,000 persons located in China. The test subjects were tested ...
February 23, 2023 | News
Eurofins Discovery Collaborating with Invasight on Cancer Therapies
Invasight is teaming with Eurofins Discovery's DiscoveryOne™, an integrated drug discovery platform that provides expert comprehensive support t...
February 15, 2023 | News
BeiGene Aim to Accelerate Integration of Mental Health into Quality Cancer Care
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, has released a report highlighting the challenges cancer patients and car...
February 03, 2023 | News
Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers
Based on positive clinical readouts from a Phase IIb study for isSCC and a Phase II study for BCC, Sirnaomics is formulating a communication package for th...
February 02, 2023 | News
TransCode Therapeutics Reports Positive Preclinical Results with its Immunotherapy Candidate, TTX-RIGA, in Melanoma
TransCode Therapeutics, Inc. (Nasdaq: RNAZ), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today repor...
February 01, 2023 | News
Genexine Receives Fast Track Designation from Korean Health Authority (MFDS) for its promising DNA vaccine for advanced cervical cancer
Following an evaluation of the full set of Phase 2 data from the recently completed clinical trial in advanced cervical cancer, Korea’s Health Author...
January 23, 2023 | News
Ferronova secures A$11 million to advance nanotech image-guided cancer therapy
Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a further A$3 million secured via an Au...
January 23, 2023 | News
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
Zhongxin launched the Program aiming to navigate and solve the medication challenges faced by cancer patients. During cancer treatment process, the use of ...
January 20, 2023 | News
Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes
Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping Lunit's presentations this year will highligh...
January 19, 2023 | News
Agilent Announces Expansion of Portfolio With Acquisition of Avida Biomed
Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine Agilent T...
January 06, 2023 | News
Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo
Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program Duality to receive upfr...
January 05, 2023 | News
The Best of 2022: FDA Approvals and the Breakthroughs That Enabled Them
For a field like cancer research, in which progress can sometimes appear to happen slowly, it is especially important to remind ourselves of the crucial ad...
December 31, 2022 | News | By Calley Jones, PhD
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
